Z-1075-2025 Class II Ongoing

Recalled by Oxoid Limited — Basingstoke

FDA device recall Z-1075-2025 was initiated by Oxoid Limited on Dec 23, 2024 and is designated Class II. Reason for recall: Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs. The recall status is ongoing. Affected quantity: 1406 units.

Recall details

Product Type
Devices
Report Date
Feb 12, 2025
Initiation Date
Dec 23, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1406 units

Product description

Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797

Reason for recall

Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.

Distribution pattern

US: VA, CA, NE, MA, FL, CA, MA, NH, WA OUS: Austria, Australia, Brazil, Canada, China, Costa Rica, Germany, Spain, France, United Kingdom, Ghana, Hong Kong, South Korea, Netherlands, Peru, Philippines, Poland, Indonesia

Code information

Lot # 6142394/UDI: 5032384079629

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1075-2025
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Oxoid Limited? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-1075-2025. Report a data issue: hello@regdatalab.com.